With the recent acquisition of the two Chinese companies, restructuring, and the addition of a new CFO, Vasomedical is now positioned to move forward and further implement plans for expansion and growth.
Further Implements Global Growth Strategy and Strengthens Manufacturing, Distribution and Technology Base
Vasomedical (OTC: VASO) President & CEO Jun Ma, Ph.D., was interviewed by OneMedRadio. Vasomedical is a Westbury, New York device company with a market cap of $39M focusing on cardiac disease.
Copyright © 2024 | WordPress Theme by MH Themes